Frequent Suboptimal Thermocycler Ramp Rate Usage Negatively Impacts GenoType MTBDRsl VER 2.0 Performance for Second-Line Drug-Resistant Tuberculosis Diagnosis-Reference-Cited by-同舟云学术

Frequent Suboptimal Thermocycler Ramp Rate Usage Negatively Impacts GenoType MTBDRsl VER 2.0 Performance for Second-Line Drug-Resistant Tuberculosis Diagnosis

Published:2022-05 Issue:5 Volume:24 Page:494-502
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Derendinger Brigitta^ORCID,de Vos Margaretha^ORCID,Pillay Samantha^ORCID,Venter Rouxjeane^ORCID,Metcalfe John^ORCID,Ghebrekristos Yonas,Minnies Stephanie,Dolby Tania,Beylis Natalie,Warren Robin,Theron Grant^ORCID

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference14 articles.

1. Global Tuberculosis Report 2020,2020

2. Averting epidemics of extensively drug-resistant tuberculosis;Basu;Proc Natl Acad Sci U S A,2009

3. Four-month rifapentine regimens with or without moxifloxacin for tuberculosis;Dorman;N Engl J Med,2021

4. The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs: policy guidance,2016

5. WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis—Rapid diagnostics for tuberculosis detection 2021 update,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial experiences withMycobacterium tuberculosisDNA extraction for downstream Deeplex Myc-TB targeted deep sequencing in a high burden setting;2023-11-23

2. To Test or Not? Xpert MTB/RIF as an Alternative to Smear Microscopy to Guide Line Probe Assay Testing for Drug-Resistant Tuberculosis;Journal of Clinical Microbiology;2023-07-20

3. To test or not? Xpert MTB/RIF as an alternative to smear microscopy to guide line probe assay testing for drug-resistant tuberculosis;2022-12-06

4. Non-actionable Results, Accuracy, and Effect of First- and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a High-Volume Laboratory;Clinical Infectious Diseases;2022-07-05